Sep 30, 2026
ImmunityBio (IBRX) Stock Surges 12% Following Bullish Hedge Fund Analysis
ImmunityBio (IBRX) stock climbed 12% after a hedge fund spotlighted Anktiva's multi-billion dollar market potential and global expansion strategy.
The post ImmunityBio (IBRX) Stock Surges 12% Following Bullish Hedge Fund Analysis appeared first on Blockonomi.
Source: Blockonomi →Related News
- 51 minutes ago
Hyperliquid Strategies Inc. (PURR) Stock: Shares Climb as Company Boosts Buyback...
- 1 hour ago
Ionis Pharmaceuticals (IONS) Stock: Falls 2.23% Despite Roche’s Breakthrough Pha...
- 2 hours ago
Hyperscale Data, Inc. (GPUS) Stock: Soars 34% as Michigan AI Data Center Nears D...
- 2 hours ago
Edible Garden AG (EDBL) Stock Falls Despite New Farm Partnership Targeting 19% G...
- 5 hours ago
Rocket Lab (RKLB) Stock: Surges as Electron Completes 98th Launch for HawkEye 36...